Reuters logo
BRIEF-Sancilio pharmaceuticals company announces the successful completion of clinical trial in pediatric patients with sickle cell disease using Altemiatm
October 3, 2017 / 11:59 AM / 2 months ago

BRIEF-Sancilio pharmaceuticals company announces the successful completion of clinical trial in pediatric patients with sickle cell disease using Altemiatm

Oct 3 (Reuters) - Sancilio Pharmaceuticals Co Inc

* Announces the successful completion of a randomized, double blind, and placebo controlled phase of a clinical trial in pediatric patients with sickle cell disease using Altemiatm

* ‍Expects to announce top-line data, including Altemia’s impact on frequency of vaso-occlusive events, in Q4 of 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below